Typhoid Fever Pipeline Review, H2 2017, provides an overview of the Typhoid Fever (Infectious Disease) pipeline landscape. The Typhoid Fever Pipeline covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Typhoid Fever – Companies Involved in Therapeutics Development
GlaxoSmithKline Plc, Indian Immunologicals Ltd, Nanotherapeutics Inc, Prokarium Ltd, Protein Potential LLC, Sanofi Pasteur SA, Shantha Biotechnics Pvt Ltd, SK Chemicals Co Ltd, Zydus Cadila Healthcare Ltd
Purchase This Single User License PDF Report of 47 pages at: http://www.reportsnreports.com/purchase.aspx?name=1132628
Typhoid fever is an infection that causes diarrhea and a rash. It is most commonly due to a type of bacterium called Salmonella typhi (S. typhi). Symptoms include abdominal tenderness, agitation, chills, delirium, hallucinations, severe fatigue and weakness. Treatment includes antibiotics and supportive therapy.
Pharmaceutical and Healthcare latest pipeline guide Typhoid Fever – Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Typhoid Fever (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Discount is available on Diarrhea report at http://www.reportsnreports.com/contacts/discount.aspx?name=1132628
The Typhoid Fever (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Typhoid Fever and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 2, 1, 1, 6, 1 and 3 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.
List of Figures
Number of Products under Development for Typhoid Fever, H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products by Targets, H2 2017
Number of Products by Stage and Targets, H2 2017
Number of Products by Routes of Administration, H2 2017
Number of Products by Stage and Routes of Administration, H2 2017
Number of Products by Molecule Types, H2 2017
Number of Products by Stage and Molecule Types, H2 2017
ReportsandReports.com is your single source for all market research needs. Our database includes 100,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
2nd Floor, Metropole,
Bund Garden Road,
Pune – 411001,
Tel: + 1 888 391 5441